Evidence map›Paper›PMID 40076306›Full record

ReviewMolecules (Basel, Switzerland)2025

Overview of Recent Advances in Rare-Earth High-Entropy Oxides as Multifunctional Materials for Next-Gen Technology Applications.

Stjepan Šarić, Jelena Kojčinović, Dalibor Tatar, Igor Djerdj

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stjepan ŠarićDepartment of Chemistry, Josip Juraj Strossmayer University of Osijek, Cara Hadrijana 8/A, HR-31000 Osijek, Croatia.ORCID 0000-0002-5276-4497
Jelena KojčinovićDepartment of Chemistry, Josip Juraj Strossmayer University of Osijek, Cara Hadrijana 8/A, HR-31000 Osijek, Croatia.ORCID 0000-0003-1420-0380
Dalibor TatarDepartment of Chemistry, Josip Juraj Strossmayer University of Osijek, Cara Hadrijana 8/A, HR-31000 Osijek, Croatia.ORCID 0000-0003-3722-7420
Igor DjerdjDepartment of Chemistry, Josip Juraj Strossmayer University of Osijek, Cara Hadrijana 8/A, HR-31000 Osijek, Croatia.ORCID 0000-0002-0646-4928

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rare-earth high-entropy oxides are a new promising class of multifunctional materials characterized by their ability to stabilize complex, multi-cationic compositions into single-phase structures through configurational entropy. This feature enables fine-tuning structural properties such as oxygen vacancies, lattice distortions, and defect chemistry, making them promising for advanced technological applications. While initial research primarily focused on their catalytic performance in energy and environmental applications, recent research demonstrated their potential in optoelectronics, photoluminescent materials, and aerospace technologies. Progress in synthesis techniques has provided control over particle morphology, composition, and defect engineering, enhancing their electronic, thermal, and mechanical properties. Rare-earth high-entropy oxides exhibit tunable bandgaps, exceptional thermal stability, and superior resistance to phase degradation, which positions them as next-generation materials. Despite these advances, challenges remain in scaling up production, optimizing compositions for specific applications, and understanding the fundamental mechanisms governing their multifunctionality. This review provides a comprehensive analysis of the recent developments in rare-earth high-entropy oxides as relatively new and still underrated material of the future.

Indexed as

catalysisCO2 hydrogenationconfiguration entropyCO oxidationhigh-entropy oxideshydrogen productionoptoelectronicsrare-earth elementssustainability

Identifiers

PMID40076306
PMCPMC11901848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.